According to a study examining the immune gene expression profiles of several CRC patient subgroups, the most immunogenic subgroup of CRC patients had higher levels of KLRK1, which was positively connected with IFNG mRNA expression and linked to a worse chance of survival [37]. Here, KLRK1 is linked to colorectal carcinoma.